Dynamics of carbohydrate metabolism indexes in patients with metabolic syndrome under complex therapy added with intravenous laser blood irradiation
https://doi.org/10.37895/2071-8004-2019-23-4-56-59
Abstract
Purpose. The paper presents results of the trial aimed to find out the influence of intravenous laser blood irradiation (ILBI) at the dynamics of carbohydrate metabolism in patients with metabolic syndrome (MS). Material and methods. 154 patients (average age 36.5 ± 3.6 years) with metabolic syndrome were examined and treated. All patients were randomly divided into two groups: control (32 patients) and studied (122 patients). In the control group, MS was treated with the standard medicamentous approach: lipid-lowering therapy, hypoglycemic drugs, antihypertensive therapy. Patients from the studied group, in addition to medicamentous treatment, had a course of laser therapy by the ILBI technique (VLOK-405). Laser device “Matrix-VLOK” (Matrix Ltd, Russia) with wavelength 0.405 mkm, output power at the tip of main fiber 1-1.5 mW was used. Laser irradiation of blood lasted for 15 minutes in continuous mode; therapy course had 10 daily procedures with an interval for Saturday and Sunday. Patients’ were examined in the morning on the first and second days and in 14 days after the laser therapy course. Results. It has been shown that the comprehensive therapy with included intravenous laser blood irradiation (ILBI) normalizes carbohydrate metabolism in patients with metabolic syndrome.
About the Authors
N. M. Burduli
North Ossetian State Medical Academy
Russian Federation
Vladikavkaz
Russian Federation
Vladikavkaz
T. G. Gaitova
North Ossetian State Medical Academy
Russian Federation
Vladikavkaz
Russian Federation
Vladikavkaz
E. Yu. Gireeva
North Ossetian State Medical Academy
Russian Federation
Vladikavkaz
Russian Federation
Vladikavkaz
References
1. Ivashkin V.T., Drapkina O.M., Korneeva O.I. Clinical variants of the metabolic syndrome. Medical Information Agency Publishing House. M., 2012: 216. [In Russ.].
2. The Consensus of Experts on the interdisciplinary approach to the management, diagnostics and treatment of patients with the metabolic syndrome. Cardiovascularnaya therapia i profilaktika. 2013; 12 (6): 41–82. [In Russ.].
3. Lopatkina L.V. On the question of the effect of non-medicamentous weight loss in metabolic syndrome. Saratovskiy nauchno-meditsinskiy zhurnal. 2013; 9 (4): 975–979. [In Russ.].
4. Mashanskaya A.V., Kirgizova O.Yu. Metabolic syndrome as a complex risk factor for the development of cardiovascular diseases and non-pharmacological methods of treatment and prevention in children and adolescents. Sibirskiy meditsinskiy zhurnal (Irkutsk). 2013; 6: 16–21. [In Russ.].
5. Misnikova I.V. Impaired carbohydrate metabolism in metabolic syndrome: diagnosis and treatment. Polyclinica. M., 2016; 1–2: 17–20. [In Russ.].
6. Chernysheva E.N., Panova T.N. The apoptosis inducer - Z53 protein and insulin resistance in the metabolic syndrome. Kubanskiy nauchnyy meditsinskiy vestnik. 2012; 2: 186–190. [In Russ.].
7. The Emerging Risk Factors Collaboration. Diabetis Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. N. Engl. J. Med. 2012; 364: 829–841.
8. Mirarefin M., Sharifi F., Fakhrzadeh H. et al. Waist circumference and insulin resistance in el derly men: an analysis of Kahrizak elderly study. J. Diabetes Metab. Dis-ors. 2014; 13 (1): 28.
Review
For citations:
Burduli N.M., Gaitova T.G., Gireeva E.Yu. Dynamics of carbohydrate metabolism indexes in patients with metabolic syndrome under complex therapy added with intravenous laser blood irradiation. Laser Medicine. 2019;23(4):56-59. (In Russ.) https://doi.org/10.37895/2071-8004-2019-23-4-56-59
Views:
212
Email this article 